Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]        
Net sales $ 39,873 $ 28,774 $ 114,091 $ 83,077
Cost of products sold 33,646 28,213 95,840 78,159
Gross profit 6,227 561 18,251 4,918
Other expenses and income:        
Selling, general and administrative 5,284 4,729 15,828 14,534
Selling, general and administrative – amortization 274 274 821 639
Other operating expense (income), net 0 140 0 (962)
Operating income (loss) 669 (4,582) 1,602 (9,293)
Other income, net (63) (111) (188) (416)
Interest income (39) (12) (71) (43)
Interest expense 333 132 768 300
Income (loss) before provision (benefit) for income taxes 438 (4,591) 1,093 (9,134)
Provision (benefit) for income taxes 70 (861) 245 (1,786)
Net income (loss) $ 368 $ (3,730) $ 848 $ (7,348)
Basic:        
Net income (loss) $ 0.03 $ (0.35) $ 0.08 $ (0.70)
Diluted:        
Net income (loss) $ 0.03 $ (0.35) $ 0.08 $ (0.70)
Weighted average common shares outstanding:        
Basic 10,611 10,638 10,613 10,507
Diluted 10,660 10,638 10,632 10,507
Dividends declared per share $ 0 $ 0.11 $ 0 $ 0.33